Myocarditis: Comprehensive Medical Management
Myocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.
Infections and Autoimmune Causes
Administer appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are confirmed, immunosuppressive therapies may be considered to mitigate inflammation, although these are used with caution due to potential risks and side effects.
General Management: Bed Rest and Activity Restriction
Bed rest is crucial for reducing cardiac workload and preventing additional myocardial damage. Young patients and athletes, in particular, should maintain bed rest and restrict activities for at least six months or until their heart function normalizes. Based on medical advice, gradually reintroduce physical activity. Patients should promptly report any symptoms such as palpitations or rapid heartbeats experienced during physical exertion.
Symptom Management
Managing symptoms of myocarditis involves several pharmacological approaches:
Pain Management and Additional Supportive Care
Nonsteroidal anti-inflammatory drugs (NSAIDs) should generally be avoided in myocarditis due to their potential to exacerbate cardiac injury and impair healing, particularly in viral myocarditis. For cases with a viral etiology, antiviral therapy may be considered.
Patient Education and Follow-up
Education about adherence to activity restrictions and medication regimens is vital. Patients should be educated on recognizing early signs of complications, such as worsening symptoms or new onset of chest pain, and should seek medical help immediately if these occur.
The medical management of myocarditis includes appropriate antimicrobial therapy, such as penicillin, when caused by bacterial infections like streptococcus pyogenes.
General supportive measures include oxygen therapy, bed rest, and a restriction in physical activities for at least six months to reduce cardiac workload.
Symptom management includes medications such as ACE inhibitors for heart failure and cardiac remodeling, beta-blockers for heart failure and symptom control, and diuretics to reduce fluid volume and preload.
For patients without hypotension, intravenous medications such as nitroprusside and milrinone can reduce afterload and improve cardiac output.
Additionally, digoxin may be used cautiously to improve heart contractility and reduce the heart rate.
Anticoagulation therapy reduces the risk of clots in patients with a low ejection fraction.
In cases of severe heart failure, intra-aortic balloon pump therapy and ventricular assist devices may be needed.
繁體中文
